Elite in Cryoglobulinemia

Massimo Galli

Via Caserta 06, 
Rome, IT 
Elite in Cryoglobulinemia
Via Caserta 06, 
Rome, IT 
OverviewLocationsClinical Research

Overview

Massimo Galli practices in Rome, Italy. Mr. Galli is rated as an Elite expert by MediFind in the treatment of Cryoglobulinemia. His top areas of expertise are Cryoglobulinemia, HIV/AIDS, Severe Acute Respiratory Syndrome (SARS), Osteotomy, and Bone Graft.

His clinical research consists of co-authoring 327 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 24 articles in the study of Cryoglobulinemia.

Gender
Male

Locations

Via Caserta 06, Rome, 00161, Italy
Other Locations
Milan, Italy
Cotignola, Italy
Lodi, 26900, Italy
Italiana, Italy
Legnano, Italy
Sapienza, Italy
Varese, Italy
Sacco, Italy
Pistoia, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Baricitinib in Patients With COVID-19 Infection
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Baricitinib in Patients With COVID-19 Infection
Enrollment Status: Completed
Publish Date: July 28, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
Switching HIV-positive Women on Tenofovir/Emtricitabine Plus Boosted Atazanavir to RALtegravir Plus Boosted ATazanavir: A Pilot Randomized Clinical Trial Investigating 48-weeks Changes in Bone Mineral Density
Switching HIV-positive Women on Tenofovir/Emtricitabine Plus Boosted Atazanavir to RALtegravir Plus Boosted ATazanavir: A Pilot Randomized Clinical Trial Investigating 48-weeks Changes in Bone Mineral Density
Enrollment Status: Terminated
Publish Date: October 17, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

327 Total Publications

Novel Pathogenic Variant Confirms the Association of REST and Jones Syndrome.
Novel Pathogenic Variant Confirms the Association of REST and Jones Syndrome.
Journal: Clinical genetics
Published: May 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Galli's expertise for a condition
ConditionClose
View All 47 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile